Your Messages Inbox
Your Article Summary
See Latest ArticlesNew Data Proves Effectiveness of Medtronic Insertable Cardiac Monitor in Detecting AF, Most Common Heart Rhythm Disorder
Medtronic, 06/24/09
Atrial fibrillation is the most common arrhythmia, affecting an estimated 7 million people worldwide, including 4.5 million in the European Union. Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc. , shows that the Medtronic Reveal XT Insertable Cardiac Monitor reliably identifies patients with AF and correctly confirms the absence of AF in patients.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Article Search
Sponsor